Identification of FIP200 interaction with the TSC1-TSC2 complex and its role in regulation of cell size control

Journal of Cell Biology

Volumn 170, Issue 3, 2005, Pages 379-389

  Gan, Boyi ^a   Melkoumian, Zara K ^a   Wu, Xiaoyang ^a   Guan, Kun Liang ^b   Guan, Jun Lin ^a  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; FOCAL ADHESION KINASE FAMILY INTERACTING PROTEIN; HAMARTIN; PROTEIN INHIBITOR; S6 KINASE; TUBERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SIZE; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; ENERGY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; UPREGULATION;

ANIMALS; CELL CYCLE; CELL SIZE; CELLS, CULTURED; ENZYME INDUCTION; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; REPRESSOR PROTEINS; RIBOSOMAL PROTEIN S6 KINASES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 23744454765     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200411106     Document Type: Article

References (45)

1. Abbi, S., H. Ueda, C. Zheng, L.A. Cooper, J. Zhao, R. Christopher, and J.L. Guan. 2002. Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol. Biol. Cell. 13:3178-3191.
2. Brugarolas, J., K. Lei, R.L. Hurley, B.D. Manning, J.H. Reiling, E. Hafen, L.A. Witters, L.W. Ellisen, and W.G. Kaelin Jr. 2004. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18:2893-2904.
3. Catania, M.G., P.S. Mischel, and H.V. Vinters. 2001. Hamartin and tuberin interaction with the G2/M cyclin-dependent kinase CDK1 and its regulatory cyclins A and B. J. Neuropathol. Exp. Neurol. 60:711-723.
4. Chano, T., S. Ikegawa, K. Kontani, H. Okabe, N. Baldini, and Y. Saeki. 2002a. Identification of RB1CC1, a novel human gene that can induce RB1 in various human cells. Oncogene. 21:1295-1298.
5. Chano, T., S. Ikegawa, F. Saito-Ohara, J. Inazawa, A. Mabuchi, Y. Saeki, and H. Okabe. 2002b. Isolation, characterization and mapping of the mouse and human RB1CC1 genes. Gene. 291:29-34.
6. Chano, T., K. Kontani, K. Teramoto, H. Okabe, and S. Ikegawa. 2002c. Truncating mutations of RB1CC1 in human breast cancer. Nat. Genet. 31:285-288.
7. Chano, T., Y. Saeki, M. Serra, K. Matsumoto, and H. Okabe. 2002d. Preferential expression of RB1-inducible coiled-coil 1 in terminal differentiated musculoskeletal cells. Am. J. Pathol. 161:359-364.
8. Dahiya, R., G. Perinchery, G. Deng, and C. Lee. 1998. Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters. Int. J. Oncol. 12:811-816.
9. Gao, X., Y. Zhang, P. Arrazola, O. Hino, T. Kobayashi, R.S. Yeung, B. Ru, and D. Pan. 2002. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell Biol. 4:699-704.
10. Garami, A., F.J. Zwartkruis, T. Nobukuni, M. Joaquin, M. Roccio, H. Stocker, S.C. Kozma, E. Hafen, J.L. Bos, and G. Thomas. 2003. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell. 11:1457-1466.
11. Goncharova, E.A., D.A. Goncharov, A. Eszterhas, D.S. Hunter, M.K. Glassberg, R.S. Yeung, C.L. Walker, D. Noonan, D.J. Kwiatkowski, M.M. Chou, et al. 2002. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J. Biol. Chem. 277:30958-30967.
12. Groszer, M., R. Erickson, D.D. Scripture-Adams, R. Lesche, A. Trumpp, J.A. Zack, H.I. Kornblum, X. Liu, and H. Wu. 2001. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science. 294:2186-2189.
13. Haddad, L.A., N. Smith, M. Bowser, Y. Niida, V. Murthy, C. Gonzalez-Agosti, and V. Ramesh. 2002. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. J. Biol. Chem. 277:44180-44186.
14. Hengstschlager, M., and M. Rosner. 2003. The cell cycle and tuberous sclerosis. Prog. Cell Cycle Res. 5:43-48.
15. Hengstschlager, M., D.M. Rodman, A. Miloloza, E. Hengstschlager-Ottnad, M. Rosner, and M. Kubista. 2001. Tuberous sclerosis gene products in proliferation control. Mutat. Res. 488:233-239.
16. Inoki, K., Y. Li, T. Zhu, J. Wu, and K.L. Guan. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4:648-657.
17. Inoki, K., Y. Li, T. Xu, and K.L. Guan. 2003a. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17: 1829-1834.
18. Inoki, K., T. Zhu, and K.L. Guan. 2003b. TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115:577-590.
19. Iritani, B.M., and R.N. Eisenman. 1999. c-Myc enhances protein synthesis and cell size during B lymphocyte development. Proc. Natl. Acad. Sci. USA. 96:13180-13185.
20. Kontani, K., T. Chano, Y. Ozaki, N. Tezuka, S. Sawai, S. Fujino, Y. Saeki, and H. Okabe. 2003. RB1CC1 suppresses cell cycle progression through RB1 expression in human neoplastic cells. Int. J. Mol. Med. 12:767-769.
21. Kwiatkowski, D.J. 2003. Tuberous sclerosis: from tubers to mTOR. Ann. Hum. Genet. 67:87-96.
22. Kwiatkowski, D.J., H. Zhang, J.L. Bandura, K.M. Heiberger, M. Glogauer, N. el-Hashemite, and H. Onda. 2002. A mouse model of TSC1 reveals sexdependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum. Mol. Genet. 11:525-534.
23. Lamb, R.F., C. Roy, T.J. Diefenbach, H.V. Vinters, M.W. Johnson, D.G. Jay, and A. Hall. 2000. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat. Cell Biol. 2:281-287.
24. Li, Y., K. Inoki, R. Yeung, and K.L. Guan. 2002. Regulation of TSC2 by 14-3-3 binding. J. Biol. Chem. 277:44593-44596.
25. Malik, R.K., and J.T. Parsons. 1996. Integrin-dependent activation of the p70 ribosomal S6 kinase signaling pathway. J. Biol. Chem. 271:29785-29791.
26. Manning, B.D., A.R. Tee, M.N. Logsdon, J. Blenis, and L.C. Cantley. 2002. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell. 10:151-162.
27. Miloloza, A., M. Rosner, M. Nellist, D. Halley, G. Bernaschek, and M. Hengstschlager. 2000. The TSC1 gene product, hamartin, negatively regulates cell proliferation. Hum. Mol. Genet. 9:1721-1727.
28. Plank, T.L., R.S. Yeung, and E.P. Henske. 1998. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Res. 58:4766-4770.
29. Potter, C.J., H. Huang, and T. Xu. 2001. Drosophila Tsc1 functions with Tsc2 to antagonize insulin signaling in regulating cell growth, cell proliferation, and organ size. Cell. 105:357-368.
30. Sage, J., G.J. Mulligan, L.D. Attardi, A. Miller, S. Chen, B. Williams, E. Theodorou, and T. Jacks. 2000. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:3037-3050.
31. Saucedo, L.J., X. Gao, D.A. Chiarelli, L. Li, D. Pan, and B.A. Edgar. 2003. Rheb promotes cell growth as a component of the insulin/TOR signalling network. Nat. Cell Biol. 5:566-571.
32. Shamji, A.F., P. Nghiem, and S.L. Schreiber. 2003. Integration of growth factor and nutrient signaling: implications for cancer biology. Mol. Cell. 12:271-280.
33. Shumway, S.D., Y. Li, and Y. Xiong. 2003. 14-3-3beta binds to and negatively regulates the tuberous sclerosis complex 2 (TSC2) tumor suppressor gene product, tuberin. J. Biol. Chem. 278:2089-2092.
34. Soucek, T., R.S. Yeung, and M. Hengstschlager. 1998. Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA. 95:15653-15658.
35. Soucek, T., M. Rosner, A. Miloloza, M. Kubista, J.P. Cheadle, J.R. Sampson, and M. Hengstschlager. 2001. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression. Oncogene. 20:4904-4909.
36. Stocker, H., T. Radimerski, B. Schindelholz, F. Wittwer, P. Belawat, P. Daram, S. Breuer, G. Thomas, and E. Hafen. 2003. Rheb is an essential regulator of S6K in controlling cell growth in Drosophila. Nat. Cell Biol. 5:559-565.
37. Sui, G., C. Soohoo, E.B. Affar, F. Gay, Y. Shi, W.C. Forrester, and Y. Shi. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA. 99:5515-5520.
38. Tapon, N., N. Ito, B.J. Dickson, J.E. Treisman, and I.K. Hariharan. 2001. The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation. Cell. 105:345-355.
39. Tee, A.R., B.D. Manning, P.P. Roux, L.C. Cantley, and J. Blenis. 2003. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13:1259-1268.
40. Tu, Y., F. Li, S. Goicoechea, and C. Wu. 1999. The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrinrich sites in spreading cells. Mol. Cell. Biol. 19:2425-2434.
41. Ueda, H., S. Abbi, C. Zheng, and J.L. Guan. 2000. Suppression of Pyk2 kinase and cellular activities by FIP200. J. Cell Biol. 149:423-430.
42. van Slegtenhorst, M., M. Nellist, B. Nagelkerken, J. Cheadle, R. Snell, A. van den Ouweland, A. Reuser, J. Sampson, D. Halley, and P. van der Sluijs. 1998. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet. 7:1053-1057.
43. Zhang, H., G. Cicchetti, H. Onda, H.B. Koon, K. Asrican, N. Bajraszewski, F. Vazquez, C.L. Carpenter, and D.J. Kwiatkowski. 2003. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112:1223-1233.
44. Zhang, Y., X. Gao, L.J. Saucedo, B. Ru, B.A. Edgar, and D. Pan. 2003. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 5:578-581.
45. Zhao, J.H., H. Reiske, and J.L. Guan. 1998. Regulation of the cell cycle by focal adhesion kinase. J. Cell Biol. 143:1997-2008.